stockportfolio.pro
Stocks / ACA vs JBTM
ACA vs JBTM
Arcosa, Inc. and JBT Marel Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.
| Arcosa, Inc. (ACA) | JBT Marel Corporation (JBTM) | |
|---|---|---|
| Market cap | $6.1B | $6.3B |
| Revenue (latest FY) | $2.88B | $3.80B |
| Net income (latest FY) | $208.40M | $-50.50M |
| Revenue growth (5y CAGR) | 8.3% | 17.1% |
| Net margin | 7.2% | -1.3% |
| Return on equity | 7.9% | -1.1% |
| P/E ratio | 27.8 | 37.0 |
| Dividend yield | 0.2% | 0.3% |
| Profitable years (of last 10) | 10 | 9 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ACA — free Open JBTM — freeFrequently asked questions
Which is bigger, ACA or JBTM?
JBT Marel Corporation is larger by market capitalization — $6.3B versus $6.1B.
Which grows faster, ACA or JBTM?
Over the last five fiscal years, JBT Marel Corporation grew revenue faster — 17.1%/yr versus 8.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.